Jardiance clinical trial deemed successful enough to stop early
The EMPA-KIDNEY clinical trial of Jardiance (empagliflozin) for adults with chronic kidney disease (CKD) was deemed successful enough to stop early by the trial’s […]
Jardiance clinical trial deemed successful enough to stop early Read More »